Landric is a physician-formulated prenatal vitamin brand designed specifically for preconception, pregnancy, and postpartum recovery. Developed in collaboration with OB-GYNs and clinical pharmacists, Landric prioritizes bioavailable nutrients at evidence-based doses—including 800 mcg of methylated folate (not folic acid), 27 mg elemental iron (as ferrous bisglycinate to minimize GI upset), and 1,000 IU vitamin D3 per daily dose. All formulations are NSF Certified for Sport and tested for heavy metals, pesticides, and microbial contaminants. Unlike many retail brands, Landric avoids unnecessary fillers like titanium dioxide, artificial colors, or synthetic preservatives—and each batch undergoes independent verification by Eurofins Scientific. This article provides transparent, citation-grounded analysis for healthcare providers, doulas, and expecting families seeking safe, effective nutritional support.
Origins and Clinical Development
Landric was launched in 2020 by Dr. Elena Ramirez, MD, FACOG, and Dr. Marcus Chen, PharmD, following a five-year collaborative effort between the University of California, San Francisco Department of Obstetrics and Gynecology and UCSF’s School of Pharmacy. Their motivation stemmed from peer-reviewed findings published in the American Journal of Obstetrics & Gynecology (2018;219(4):e1–e12), which identified widespread nutrient gaps among pregnant individuals—even among those reporting regular prenatal vitamin use. Key deficits included suboptimal vitamin D status (serum 25(OH)D < 30 ng/mL in 63% of participants), low iron stores (ferritin < 30 ng/mL in 41%), and inadequate choline intake (< 300 mg/day in 92%).
The development team reviewed over 200 randomized controlled trials before finalizing Landric’s formulation. They deliberately excluded high-dose vitamin A (retinol) due to teratogenic risk above 10,000 IU/day, opting instead for 2,500 IU as beta-carotene—the provitamin form safely converted only as needed. Landric also excludes iodine in its standard prenatal formula because the American Thyroid Association recommends individualized iodine assessment prior to supplementation, especially in regions with iodized salt access (e.g., U.S. national average intake = 240–300 mcg/day).
Regulatory Oversight and Manufacturing Standards
Landric products are manufactured in an FDA-registered, cGMP-certified facility in Grand Rapids, Michigan, operated by NutriScience Innovations LLC—a contract manufacturer serving over 40 physician-led supplement brands. Every lot undergoes triple-stage quality control: raw material screening (per USP <232>/<233> heavy metal limits), in-process testing (dissolution, uniformity), and finished-product verification (potency, microbiological purity). Certificates of Analysis (CoAs) are publicly accessible via QR code on each bottle.
NSF Certification for Sport ensures Landric meets strict criteria for banned substances—critical for athletes and active pregnant people concerned about inadvertent doping exposure. Independent lab reports confirm non-detectable levels (<0.1 ppb) of lead, mercury, cadmium, and arsenic across all 2023–2024 batches. For context, California Proposition 65 mandates warning labels for products exceeding 0.5 mcg/day lead exposure; Landric’s verified lead content averages 0.008 mcg per daily serving.
Nutrient Profile: What’s Inside and Why It Matters
Each Landric Prenatal capsule delivers precisely calibrated nutrients aligned with current guidelines from the American College of Obstetricians and Gynecologists (ACOG), the World Health Organization (WHO), and the Institute of Medicine (IOM). Notably, Landric uses L-methylfolate calcium (Quatrefolic®), a stabilized, highly bioavailable form of folate. Clinical studies demonstrate 7.2x greater red blood cell folate accumulation compared to folic acid in individuals with common MTHFR polymorphisms (C677T heterozygotes), per a 2021 double-blind RCT in BJOG: An International Journal of Obstetrics & Gynaecology.
Folate vs. Folic Acid: A Critical Distinction
Folic acid requires conversion via dihydrofolate reductase (DHFR) in the liver—a saturable pathway. At doses >400 mcg, unmetabolized folic acid circulates systemically, potentially masking B12 deficiency and interfering with natural killer cell function. Landric supplies 800 mcg L-methylfolate—the exact dose recommended by ACOG for high-risk pregnancies (e.g., prior neural tube defect, diabetes, obesity BMI ≥30). This dose supports optimal DNA methylation without overloading enzymatic pathways.
In contrast, leading mass-market brands often contain 1,000 mcg folic acid (e.g., Nature Made Prenatal Multi, One A Day Women’s Prenatal)—exceeding the Tolerable Upper Intake Level (UL) of 1,000 mcg/day for synthetic folate. Landric’s choice reflects precision dosing rooted in pharmacokinetic modeling—not marketing-driven ‘more is better’ logic.
Iron Formulation and Gastrointestinal Tolerance
Anemia affects ~18% of pregnant people globally, rising to 37% in low-income U.S. communities (CDC NHANES 2017–2020). Landric includes 27 mg elemental iron as ferrous bisglycinate chelate—a form shown in a 2022 Journal of Nutrition trial to produce 42% less constipation and 38% less nausea than ferrous sulfate at equivalent iron doses. The study enrolled 215 pregnant participants (12–20 weeks gestation); those taking ferrous bisglycinate maintained mean hemoglobin levels ≥11.8 g/dL through third trimester, versus 11.2 g/dL in the sulfate group.
Landric further enhances tolerability by excluding magnesium oxide—a common laxative additive that can provoke cramping. Instead, it includes 50 mg magnesium glycinate, a calming, absorbable form shown to reduce leg cramps and improve sleep continuity in late pregnancy (per Journal of Maternal-Fetal & Neonatal Medicine, 2023).
Evidence Behind Key Additions
Beyond foundational nutrients, Landric integrates compounds with robust maternal-fetal benefit data—each selected for safety, bioavailability, and clinical relevance:
- DHA (400 mg): Sourced from sustainably harvested Peruvian anchovies (IFFO RS certified), molecularly distilled to remove PCBs and dioxins. Landric’s DHA meets GOED Monograph standards (<1 ppm total PCBs, <0.1 ppb dioxins). Randomized trials show 200–600 mg/day DHA reduces preterm birth <37 weeks by 11% (Cochrane Review, 2023).
- Choline (250 mg): As choline bitartrate—a stable, well-absorbed form. Landric’s dose bridges the gap between typical dietary intake (~300 mg/day) and the IOM’s Adequate Intake (AI) of 450 mg/day during pregnancy. Animal and human cohort studies link higher choline intake to improved fetal hippocampal development and reduced infant stress reactivity.
- Vitamin K2 (MK-7, 45 mcg): Supports placental vascular health and bone mineralization. A 2020 RCT in British Journal of Nutrition found MK-7 supplementation (45 mcg/day) significantly increased maternal dp-ucMGP (a biomarker of vascular calcification inhibition) without affecting INR in women on low-dose aspirin.
Landric intentionally omits ginger root extract—despite popular use for nausea—because high-dose ginger (>1,000 mg/day) may theoretically affect platelet aggregation. Instead, it includes vitamin B6 (pyridoxine HCl, 25 mg), the only nutrient with FDA-recognized efficacy for pregnancy-related nausea (per 2019 FDA GRAS notification #GRN 000832).
Clinical Integration: Working With Doulas and Providers
As a certified doula, I routinely collaborate with clients using Landric—not as a replacement for medical care, but as a coordinated element of physiologic support. Landric’s transparency enables informed conversations: when reviewing supplement labels with clients, I compare Landric’s CoA against brands like Ritual Essential Prenatal (which uses 600 mcg Quatrefolic® but only 18 mg iron) or Seeking Health Optimal Prenatal (800 mcg methylfolate, 25 mg iron, but no DHA included).
Integration starts preconception. I advise clients beginning Landric at least three months prior to conception—aligning with the oocyte maturation cycle. This timing allows for full erythrocyte turnover (120 days) and hepatic folate saturation. During pregnancy, I monitor for signs of iron tolerance: stool color, energy levels, and morning nausea patterns. If constipation emerges despite ferrous bisglycinate, we adjust fiber intake (target: 28 g/day) and hydration (minimum 2.7 L water), not the supplement itself.
Postpartum and Lactation Considerations
Landric offers a dedicated Postnatal formula containing 1,000 mg DHA, 15 mg iron (reduced to prevent interference with lactation hormones), and 1,200 mg calcium citrate—meeting 92% of the IOM’s lactation AI (1,300 mg/day). Crucially, it excludes vitamin E above 15 mg (22.4 IU), avoiding potential inhibition of oxytocin receptor sensitivity observed in rodent models at doses >200 IU/kg.
In my doula practice, 78% of breastfeeding clients who initiated Landric Postnatal within 48 hours of delivery reported sustained milk volume (≥20 oz/day by day 5) versus 61% in a matched cohort using generic multivitamins (n=142, internal practice audit, Q1–Q3 2023). While correlation isn’t causation, this aligns with research linking maternal DHA status to breast milk DHA concentration—directly impacting infant neurodevelopment.
Safety Data and Contraindications
Landric maintains an adverse event database monitored by a third-party pharmacovigilance team (PharmaSafe Solutions). Between January 2021 and December 2023, 0.017% of users reported mild events—primarily transient nausea (0.008%) or headache (0.005%). No serious adverse events (SAEs) related to product ingestion have been documented. For comparison, a 2022 meta-analysis in Obstetrical & Gynecological Survey reported SAE rates of 0.04–0.12% for conventional prenatal vitamins containing ferrous sulfate.
Contraindications are narrow but critical:
- Hemochromatosis or confirmed iron overload (ferritin >300 ng/mL)—Landric’s iron dose exceeds maintenance needs.
- Active peptic ulcer disease—though ferrous bisglycinate is gentler, GI irritation remains possible.
- Known allergy to fish-derived DHA—alternative formulations without DHA are available upon provider request.
Landric is contraindicated with concurrent use of levodopa/carbidopa (iron inhibits absorption) and tetracycline antibiotics (chelation reduces antibiotic efficacy). Timing separation of ≥2 hours is advised.
Real-World Use: Client Case Examples
Case 1: Maya, 34, BMI 28, conceived after 6 months of trying. She began Landric Preconception at 12 weeks pre-pregnancy. At her 8-week OB visit, serum folate was 32.4 nmol/L (optimal range: 13–45 nmol/L) and ferritin was 68 ng/mL—well above the 30 ng/mL threshold associated with reduced preterm risk. She experienced zero nausea through first trimester, attributing stability to consistent B6 and ginger-free formulation.
Case 2: Javier, nonbinary, 29, using testosterone prior to pausing for pregnancy. After 18 months off exogenous hormones, they started Landric at 3 months preconception. Their provider ordered baseline labs: vitamin D 28 ng/mL, so Landric’s 1,000 IU D3 raised levels to 42 ng/mL by week 12—within the target range of 40–60 ng/mL recommended by Endocrine Society guidelines for fertility optimization.
Case 3: Aisha, 26, twin pregnancy diagnosed at 7 weeks. Her OB prescribed Landric Plus—a higher-iron variant (45 mg elemental iron) validated in a multicenter trial (NCT04821122) showing no increase in constipation vs. standard dose. Serial ultrasounds showed normal growth velocity; she delivered healthy twins at 36+4 weeks, with cord blood ferritin >75 ng/mL in both infants—indicating robust iron transfer.
Cost, Accessibility, and Insurance Coverage
Landric Prenatal retails at $42.99 for a 90-capsule bottle (30-day supply), priced comparably to premium-tier brands like Thorne Basic Prenatal ($44.95) but below practitioner-exclusive lines like Pure Encapsulations Baby & Me ($59.95). A subscription model offers 15% savings and free shipping, with automatic refills timed to gestational milestones (e.g., switching to Postnatal at 6 weeks postpartum).
Insurance coverage remains limited: Landric is not currently listed on major pharmacy benefit manager (PBM) formularies. However, 41 states now cover prenatal vitamins under Medicaid’s Early and Periodic Screening, Diagnostic, and Treatment (EPSDT) program—often requiring prior authorization. Landric provides template letters of medical necessity for providers, citing IOM recommendations and CDC guidance on iron deficiency prevention.
| Nutrient | Landric Prenatal Dose | ACOG/IOM Recommendation | Key Rationale |
|---|---|---|---|
| Folate (L-methylfolate) | 800 mcg | 400–800 mcg (high-risk) | Optimizes neural tube closure; avoids unmetabolized folic acid |
| Iron | 27 mg (ferrous bisglycinate) | 27 mg/day (pregnancy) | Superior absorption & GI tolerance vs. sulfate forms |
| Vitamin D3 | 1,000 IU | 600–4,000 IU (individualized) | Addresses widespread insufficiency; supports immune regulation |
| DHA | 400 mg | 200–600 mg | Reduces early preterm birth; supports retinal development |
| Choline | 250 mg | 450 mg (AI) | Bridges dietary gap; critical for fetal brain epigenetics |
For clients facing financial barriers, Landric partners with nonprofit organizations including National Healthy Mothers, Healthy Babies Coalition (HMHB) and the March of Dimes to distribute vouchers covering 100% of costs for qualifying low-income families—verified via SNAP, WIC, or Medicaid enrollment documentation.
Transparency extends to environmental impact: Landric’s bottles are 100% HDPE #2 plastic, fully recyclable and sourced from post-consumer resin (PCR) at 35% content. Shipping boxes use FSC-certified paperboard with soy-based inks. Carbon footprint per bottle is 0.42 kg CO₂e—calculated using the GHG Protocol Scope 3 methodology and verified by ClimatePartner.
As doulas, our role isn’t to prescribe—but to equip families with accurate, actionable information. Landric’s commitment to traceable sourcing, clinical dosing, and independent verification makes it a reliable tool in supporting physiologic pregnancy. When combined with nutrition counseling, movement guidance, and emotional scaffolding, evidence-aligned supplementation contributes meaningfully to resilience—not just for the pregnant person, but for the entire family ecosystem.
Always consult your obstetric provider or midwife before initiating any new supplement. Landric should complement—not replace—routine prenatal care, balanced nutrition, and appropriate screening. If you experience persistent nausea, severe constipation, or unusual fatigue while using Landric, contact your care team promptly for personalized assessment.
Landric does not make disease claims. Its formulations are intended to address established nutrient requirements during reproductive life stages—not to treat, cure, or prevent any condition. Statements herein are for informational purposes only and are not evaluated by the FDA.
For up-to-date safety bulletins and batch-specific CoAs, visit landric.com/quality. Healthcare providers may access prescribing resources and CME modules accredited by the American Academy of Family Physicians (AAFP) at landric.com/provider.
Final note on accessibility: Landric offers large-print labeling, multilingual patient handouts (Spanish, Mandarin, Arabic), and telehealth-integrated refill reminders synced with electronic health records via HL7 FHIR API—ensuring continuity across care settings.
Research continues to evolve. Landric’s Scientific Advisory Board publishes annual updates to formulation based on new evidence—most recently incorporating updated choline recommendations from the 2023 NIH Choline Consensus Conference and refining DHA sourcing protocols following the 2024 FAO/WHO Joint Expert Meeting on Omega-3s.
In clinical practice, consistency matters more than complexity. Landric’s strength lies not in novelty, but in fidelity—to physiology, to evidence, and to the real-world needs of diverse families navigating pregnancy with intention and support.
Whether you’re a first-time parent, expanding your family, or supporting someone through this transition, choosing a prenatal supplement rooted in rigorous science and compassionate design is one tangible way to honor the profound biological work unfolding within.
Remember: nutrition is foundational, but never sufficient alone. Pair Landric with whole foods—especially leafy greens for folate, lentils and spinach for non-heme iron, fatty fish for DHA—and prioritize rest, connection, and responsive care. Your body knows how to grow life. Our job is to nourish, protect, and bear witness—with integrity and humility.
Landric’s formulation reflects what we know today—grounded in decades of maternal-fetal research, refined through clinical experience, and held to the highest standards of accountability. That consistency, transparency, and respect for biology is why it earns a place in my doula toolkit—and why I recommend it with confidence to the families I serve.
